series-c-plus
Stage
2017
Founded
2
Investors
About
Ultima Genomics develops a high-throughput, low-cost sequencing platform designed to enable widespread genomic analysis. Their technology aims to significantly reduce the cost of whole human genome sequencing.
Explore Ultima Genomics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.